PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
QSI vs. DNA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between QSI and DNA is 0.49, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.5

Performance

QSI vs. DNA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Quantum-Si incorporated (QSI) and Ginkgo Bioworks Holdings, Inc. (DNA). The values are adjusted to include any dividend payments, if applicable.

0.00%100.00%200.00%300.00%SeptemberOctoberNovemberDecember2025February
95.86%
78.24%
QSI
DNA

Key characteristics

Sharpe Ratio

QSI:

0.08

DNA:

-0.70

Sortino Ratio

QSI:

2.08

DNA:

-1.11

Omega Ratio

QSI:

1.24

DNA:

0.88

Calmar Ratio

QSI:

0.17

DNA:

-0.78

Martin Ratio

QSI:

0.35

DNA:

-1.06

Ulcer Index

QSI:

45.45%

DNA:

72.55%

Daily Std Dev

QSI:

205.82%

DNA:

109.71%

Max Drawdown

QSI:

-95.33%

DNA:

-99.10%

Current Drawdown

QSI:

-85.84%

DNA:

-97.69%

Fundamentals

Market Cap

QSI:

$304.01M

DNA:

$791.48M

EPS

QSI:

-$0.64

DNA:

-$12.89

Total Revenue (TTM)

QSI:

$1.87M

DNA:

$183.20M

Gross Profit (TTM)

QSI:

-$71.00K

DNA:

$120.09M

EBITDA (TTM)

QSI:

-$74.29M

DNA:

-$338.01M

Returns By Period

In the year-to-date period, QSI achieves a -28.89% return, which is significantly lower than DNA's 40.22% return.


QSI

YTD

-28.89%

1M

-14.29%

6M

95.92%

1Y

12.94%

5Y*

N/A

10Y*

N/A

DNA

YTD

40.22%

1M

27.15%

6M

78.60%

1Y

-76.58%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

QSI vs. DNA — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

QSI
The Risk-Adjusted Performance Rank of QSI is 6161
Overall Rank
The Sharpe Ratio Rank of QSI is 4848
Sharpe Ratio Rank
The Sortino Ratio Rank of QSI is 8080
Sortino Ratio Rank
The Omega Ratio Rank of QSI is 7575
Omega Ratio Rank
The Calmar Ratio Rank of QSI is 5353
Calmar Ratio Rank
The Martin Ratio Rank of QSI is 4949
Martin Ratio Rank

DNA
The Risk-Adjusted Performance Rank of DNA is 1111
Overall Rank
The Sharpe Ratio Rank of DNA is 1111
Sharpe Ratio Rank
The Sortino Ratio Rank of DNA is 99
Sortino Ratio Rank
The Omega Ratio Rank of DNA is 1212
Omega Ratio Rank
The Calmar Ratio Rank of DNA is 55
Calmar Ratio Rank
The Martin Ratio Rank of DNA is 1919
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

QSI vs. DNA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Quantum-Si incorporated (QSI) and Ginkgo Bioworks Holdings, Inc. (DNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for QSI, currently valued at 0.08, compared to the broader market-2.000.002.004.000.08-0.70
The chart of Sortino ratio for QSI, currently valued at 2.08, compared to the broader market-6.00-4.00-2.000.002.004.006.002.08-1.11
The chart of Omega ratio for QSI, currently valued at 1.24, compared to the broader market0.501.001.502.001.240.88
The chart of Calmar ratio for QSI, currently valued at 0.17, compared to the broader market0.002.004.006.000.17-0.78
The chart of Martin ratio for QSI, currently valued at 0.35, compared to the broader market0.0010.0020.0030.000.35-1.06
QSI
DNA

The current QSI Sharpe Ratio is 0.08, which is higher than the DNA Sharpe Ratio of -0.70. The chart below compares the historical Sharpe Ratios of QSI and DNA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.50SeptemberOctoberNovemberDecember2025February
0.08
-0.70
QSI
DNA

Dividends

QSI vs. DNA - Dividend Comparison

Neither QSI nor DNA has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

QSI vs. DNA - Drawdown Comparison

The maximum QSI drawdown since its inception was -95.33%, roughly equal to the maximum DNA drawdown of -99.10%. Use the drawdown chart below to compare losses from any high point for QSI and DNA. For additional features, visit the drawdowns tool.


-100.00%-95.00%-90.00%-85.00%-80.00%-75.00%-70.00%-65.00%SeptemberOctoberNovemberDecember2025February
-85.84%
-97.69%
QSI
DNA

Volatility

QSI vs. DNA - Volatility Comparison

The current volatility for Quantum-Si incorporated (QSI) is 23.17%, while Ginkgo Bioworks Holdings, Inc. (DNA) has a volatility of 38.12%. This indicates that QSI experiences smaller price fluctuations and is considered to be less risky than DNA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


20.00%40.00%60.00%80.00%100.00%SeptemberOctoberNovemberDecember2025February
23.17%
38.12%
QSI
DNA

Financials

QSI vs. DNA - Financials Comparison

This section allows you to compare key financial metrics between Quantum-Si incorporated and Ginkgo Bioworks Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab